Brain noradrenaline and the mechanisms
of action of antidepressant drugs
by
Svensson TH
Department of Physiology and Pharmacology,
Karolinska Institutet,
Stockholm, Sweden.
Acta Psychiatr Scand Suppl 2000; 402:18-27

ABSTRACT

The basic mechanisms of action of presently used antidepressant drugs are still far from understood. This review will address a few critical issues in this area, namely (i) putative mechanisms underlying the delay in onset of action of monoamine reuptake inhibitors and potential limitations to the efficacy of these drugs, (ii) the significance of stress-induced activation of the locus coeruleus noradrenergic system for the function of the mesolimbic reward system and the effect of chronic antidepressant treatment within this context and (iii) the interaction between brain noradrenaline and 5-hydroxytryptamine systems and its significance for antidepressant drug action. Recent preclinical and clinical research which suggest novel strategies to enhance antidepressant drug efficacy will also be discussed. From this review emerges the notion that facilitation of brain noradrenergic neurotransmission may represent a more fundamental means to achieve maximal response in major depression than hitherto understood.

Stress
Selectivity
Reboxetine
NARIs v SSRIs
Noradrenaline and mood
Alpha2 receptor blockade
Noradrenaline and cognition
Antidepressant mechanisms
Noradrenergic antidepressants
Noradrenaline and cerebral aging
Reboxetine and social functioning
Reboxetine and psychomotor function
Noradrenaline/positive emotional bias
Reboxetine and GABA-noradrenergic interaction
Noradrenaline versus SSRIs: the septo-hippocampal system

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family